
Loading, please wait...

Loading, please wait...

A systematic review and meta-analysis evaluated radial endobronchial ultrasound for diagnosing peripheral pulmonary lesions that are not easily reached with conventional bronchoscopy. The pooled evidence showed a useful diagnostic yield across a large number of lesions, with a relatively low complication rate. Performance varied according to lesion characteristics and procedural factors, reinforcing that radial EBUS is a technique whose yield depends on careful localization, lesion selection, and operator skill. Clinically, the study supports radial EBUS as an important option in the expanding diagnostic toolkit for pulmonary nodules and peripheral lesions, particularly when a minimally invasive approach is preferred. It can help clinicians obtain tissue while potentially avoiding complications associated with transthoracic or surgical procedures. For HCPs, the key is to think of radial EBUS as part of a pathway rather than as a stand-alone technology: CT review, lesion accessibility, navigation strategy, pathology coordination, and backup plans all matter. The findings map directly onto the conference workshop on linear and radial EBUS and reinforce the broader interventional-pulmonology theme of choosing the right bronchoscopic tool for the clinical problem.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review and meta-analysis evaluated radial endobronchial ultrasound for diagnosing peripheral pulmonary lesions that are not easily reached with conventional bronchoscopy. The pooled evidence showed a useful diagnostic yield across a large number of lesions, with a relatively low complication rate. Performance varied according to lesion characteristics and procedural factors, reinforcing that radial EBUS is a technique whose yield depends on careful localization, lesion selection, and operator skill. Clinically, the study supports radial EBUS as an important option in the expanding diagnostic toolkit for pulmonary nodules and peripheral lesions, particularly when a minimally invasive approach is preferred. It can help clinicians obtain tissue while potentially avoiding complications associated with transthoracic or surgical procedures. For HCPs, the key is to think of radial EBUS as part of a pathway rather than as a stand-alone technology: CT review, lesion accessibility, navigation strategy, pathology coordination, and backup plans all matter. The findings map directly onto the conference workshop on linear and radial EBUS and reinforce the broader interventional-pulmonology theme of choosing the right bronchoscopic tool for the clinical problem.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back